603108 润达医疗
2024/09 - 九个月
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入6,176,286-10.36%9,147,37310,494,4198,860,1087,069,156
减:营业总成本5,921,641-8.95%8,651,9939,643,2848,160,2466,523,570
    其中:营业成本4,592,847-10.12%6,715,7457,557,0676,468,0945,157,435
               财务费用236,624-1.63%316,682323,591291,634241,605
               资产减值损失(3,692)912.79%(34,500)(40,772)(7,299)(737)
公允价值变动收益----------(3,589)
投资收益97,819-48.59%231,999137,048137,876139,857
    其中:对联营企业和合营企业的投资收益96,741-4.24%139,609138,057133,628133,634
营业利润258,447-52.61%646,803816,373777,798643,762
利润总额260,985-52.95%655,555819,651780,456635,836
减:所得税费用118,883-15.67%212,920164,541182,255132,005
净利润142,103-65.65%442,636655,110598,201503,830
减:非控股权益91,678-29.59%169,339237,364217,972173,849
股东净利润50,425-82.21%273,296417,746380,229329,981

市场价值指针
每股收益 (元) *0.080-83.67%0.4700.7200.6600.570
每股派息 (元) *----0.1000.150--0.114
每股净资产 (元) *7.0673.12%7.0606.5195.7855.337
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容